Director/PDMR Shareholding

RNS Number : 8819E
GlaxoSmithKline PLC
01 October 2008
 




Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons


I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.


On 30 September 2008, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares at a price of £12.07 per share and ADSs at a price of $43.49 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2008 to 30 September 2008:


Non Executive Director

Ordinary Shares

American Depository Shares (ADSs)

Sir Christopher Gent

2,796.19


Prof. Sir Roy Anderson

543.70


Dr Stephanie Burns


601.11

Mr Lawrence Culp


1,202.22

Sir Crispin Davis

1,553.44


Sir Deryck Maughan


1,202.22

Dr Daniel Podolsky


772.86

Sir Ian Prosser

1,087.41


Dr Ronaldo Schmitz

621.38


Mr Tom de Swaan

543.70


Sir Robert Wilson

491.92



The Company and the Non-Executive Directors were informed of these allocations on October 2008.


This notification relates to transactions notified in accordance with Disclosure and
Transparency 
Rule 3.1.4R(1)(a).


S M Bicknell

Company Secretary

1 October 2008


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQFLFBVBBFFBV

Companies

GSK (GSK)
UK 100

Latest directors dealings